Australian Journal of Basic and Applied Sciences,۵(١ ١):١ ٠ ٠ ۶ -١ ٠ ٠ ٩,٢ ٠ ١ ١ ISSN١ ٩ ٩ ١ -٨ ١ ٧ ٨
Corresponding Author: Ashkan Divanbeigi, Shefa Neuroscience Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Tel: +٩ ٨ ٩ ١ ٢ ٣ ٨ ٩ ۶ ٣ ٩ ٧; E-mail: [email protected] ١ ٠ ٠ ۶
Impulse Oscillometry System in Patients with Stable COPD:
A Retrospective Study in Tehran-Iran
١
Ghasem Azimi,
٢Ashkan Divanbeigi
١
Department of Internal Medicine, Medical Faculty, Shahed University, Tehran, Iran.
٢
Shefa Neuroscience Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:This study was aimed to evaluate the impulse oscillometry (R٢ ٠/X۵ in patients with COPD in Tehran, Iran. In a retrospective cross sectional study, we selected١ ٠ ١ patients who had PFT and impulse oscillometry records. We considered three groups for patients on the basis of spirometric findings: mild (FEV١ > ٧ ۵ %), moderate (FEV١ = ۵ ٠ %-٧ ۵ %), and severe (FEV١ < ۵ ٠ %) with FEV١/FVC <٧ ٠ % in all the groups. The analysis of variance (ANOVA) showed the statistically significant difference among mild and severe groups as well as among moderate and severe groups.
But there was no significant difference between mild and moderate patients (p >٠ .٠ ٠ ۵). There was a significant positive correlation between R٢ ٠, X۵ and FEV١, FVC, PEF, TLC (p < ٠ .٠ ۵). R٢ ٠ was significantly correlated with FVC (r=٠ .٣ ۶ ٢ for the moderate group and r=-٠ .٢ ٧ ۵ for the severe group), FEV١ (only in mild group r=٠ .۴ ٣ ۴) and FEVl/FVC (r=-٠ .٢ ۶ ۵ for the mild group and r=٠ .٢ ٢ ٣ for the moderate group). X۵ was correlated with FEV ١ (only in the mild group r=٠ .٢ ٨ ٢), and FEVl/FVC(r=٠ .۴ ٩ ١ for the mild group and r=٠ .٣ ۴ ٩ for the severe group). Sensitivity for X۵ in severe COPD group was ٧ ۴ % and in mild group, sensitivity of R٢ ٠ was ٨ ١ %. IOS can be used as an alternative of spirometry to assess COPD severity in patients with minimal cooperation.
Key words:COPD, Spirometry, Impulse, oscillometry.
INTRODUCTION
COPD is a major cause of disability and it's the third leading cause of death in the United States. More than ١ ٢ million people are currently diagnosed with COPD. Many more people may have the disease and not even know it (Rabeet al.,٢ ٠ ٠ ٧). COPD develops slowly; symptoms often worsen over time and can limit the ability to do routine activities. Severe COPD may prevent patients from doing even basic activities like walking, cooking, or taking care of themselves. Most of the time, COPD is diagnosed in middle-aged or older people.
The disease isn't passed from person to person. COPD has no cure yet, and scientists don't know how to reverse the damage to the airways and lungs. However, treatments and lifestyle changes can help patients feel better, stay more active, and slow the progress of the disease (Rabeet al.,٢ ٠ ٠ ٧; Halbertet al.,٢ ٠ ٠ ۶ ).
Spirometry is the method of choice for evaluating obstructive lung disease such as COPD. The diagnosis of COPD was confirmed by having a positive history and FEV١/FVC less than٧ ٠ % after applying bronchodilator in spirometry according to GOLD guidelines (Rabeet al.,٢ ٠ ٠ ٧). Forced Expiratory Volume in the١st second is one of the diagnostic and severity indicators of obstructive lung diseases. Evaluation of this parameter depends on patient's cooperation (Rabeet al.,٢ ٠ ٠ ٧; Ko١sumet al.,٢ ٠ ٠ ٩).
Impulse Oscillometry system (IOS) was introduced to resolve previous problems. The measurement of airflow resistance during normal breathing requires no maximal forced expiratory efforts and does not subject patients to bronchoprovocation from forced expiration. Resistance is distributed between large airways and smaller more peripheral airways, with distinct patterns attributable to each. This technique is applied when the patient is breathing normally (Laprad and Lutchen,٢ ٠ ٠ ٨). Previous reports have studied Impulse Oscillometry for evaluation of chronic respiratory disease in children and adults. Ios shows airway resistance (R) and reactance (X) values at multiple frequencies of۵ Hz(۵ -٢ ٠Hz) (Kandaet al.,٢ ٠ ١ ٠; Kubotaet al.,٢ ٠ ٠ ٩).
This study was aimed to evaluate the IOS (R٢ ٠/X۵) in patients with COPD in Tehran, Iran.
MATERIALS AND METHODS
This is a retrospective cross sectional study. We reviewed the all documents of patients suffering from COPD who had been referred to the Azimi's private clinic of pulmonary disorders between٢ ٠ ١ ٠ and٢ ٠ ١ ١ in Tehran.
We selected ١ ٠ ١ patients who had PFT and impulse oscillometry records. Spirometry and impulse oscillometry had been evaluated using "Master Screen -IOS; Master lab Erich Jaeger, Germany". We considered
۵ ۱۱ ۱۰۰۶-۱۰۰۹ ۲۰۱۱ Aust. J. Basic & Appl. Sci., ( ): ,
١ ٠ ٠ ٧
three groups for patients n the basis of spirometry findings: mild (FEV١ >٧ ۵ %), moderate (FEV١ =۵ ٠ %-٧ ۵ %), and severe (FEV١ < ۵ ٠ %) with FEV١/FVC <٧ ٠ % in all the groups. A quantitative variables described by mean±SD. Analysis of variance (ANOVA) was used for evaluating of relationship between impulse oscillometry values and different stage of COPD. The Pearson's test was analyzed the correlation between impulse oscillometry values and functional parameters. We used the healthy group data from GOLD guidelines;
cut off points of impulse osillometry parameters were determined for calculating the sensitivity, specificity, negative and positive predictive values of IOS for COPD severity detection. P value <=٠ .٠ ۵ was considered as statistically significant.
Results:
Table١ shows the demographic data and PFT values.
Table١: Characteristics of Patients.
Mild Moderate Severe All groups p value*
Number ٣ ٣ ۴ ٣ ٢ ۵ ١ ٠ ١
Age 68±18 74±11 76±12 73±16 p >٠ .٠ ۵
Weight 64±5 70±8 67±9 66±10 p >٠ .٠ ۵
IOS(R٢ ٠) 0.31±0.14 0.38±0.19 0.41±0.08 0.35±0.22 p <٠ .٠ ١
IOS(X۵) -0.15 ± 0.26 -0.20 ± 0.19 -0.34 ± 0.44 -0.27 ± 0.41 p <٠ .٠ ٢
FEV١ % 90±6 63±8 39±6 64±31 p <٠ .٠ ٠ ١
FVC % 94±5 74±8 64±13 76±11 p <٠ .٠ ٠ ١
PEF % 92±9 70±21 44±18 68±29 p <٠ .٠ ١
TLC % 98±8 97±12 97±20 97±46 p <٠ .٠ ١
*Analyzed by analysis of variance (ANOVA).
Table٢: Correlation factors between X۵, R٢ ٠ and PFT.
X۵ r٢* R٢ ٠ r٢
FEV١ ٠ .١ ۴ ٠ .١ ۶
FVC ٠ .١ ٣ ٠ .١ ۴
PEF ٠ .١ ٧ ٠ .١ ٨
TLC ٠ .١ ۴ ٠ .١ ٢
r٢= Coefficient of determination
A significant increase in R٢ ٠ was seen in severe group in comparison with others, while X۵ had a decrease in groups. The analysis of variance (ANOVA) showed the statistically significant difference among mild and severe groups as well as among moderate and severe groups. But there was no significant difference between mild and moderate patients (p > ٠ .٠ ٠ ۵). There was a significant positive correlation between R٢ ٠, X۵ and FEV١, FVC, PEF, TLC (p <٠ .٠ ۵) (Table٢).
R٢ ٠ was significantly correlated with FVC (r=٠ .٣ ۶ ٢ for the moderate group and r=-٠ .٢ ٧ ۵ for the severe group), FEV١ (only in mild group r=٠ .۴ ٣ ۴) and FEVl/FVC (r=-٠ .٢ ۶ ۵ for the mild group and r=٠ .٢ ٢ ٣ for the moderate group).
X۵ was correlated with FEV١ (only in the mild group r=٠ .٢ ٨ ٢), and FEVl/FVC(r=٠ .۴ ٩ ١ for the mild group and r=٠ .٣ ۴ ٩ for the severe group).
Sensitivity, specificity, negative and positive predictive values of IOS for COPD severity detection are described in Tables٣.
Table٣: Sensitivity, specificity, negative and positive predictive values of lOS and spirometry in COPD groups.
Variable Sensitivity
٩ ۵ %CI Specificity ٩ ۵ %CI
+LR -LR +PV -PV
R٢ ٠ ٨ ١ .٠ ٢
٧ ۴ .٩ -٨ ۶ .٢ ٨ ٢ .٨ ٨
٧ ۵ .۶ -٨ ٧ .١ ٢ .۴
٠ .٣ ۶ ۶ ٩ .٨ ٧ ۴ .٢ Mild
X۵ ٧ ٠ .٣ ٨
۶ ٠ .۶ -٨ ١ .٣ ٨ ٠ .٨ ٠
٨ ١ .۴ -٩ ۵ .٨ ۴ .٩
٠ .۶ ٢ ٨ ١ .٨ ۶ ٢ .١
R٢ ٠ ۶ ٣ .٠ ٧
۴ ٠ .٣ -٧ ١ .٠ ٧ ٧ .٣ ۵
٧ ۴ .۶ -٩ ١ .٨ ٢ .٣ ۵
٠ .۶ ٧ ۶ ٣ .۵ ۶ ۶ .٠ Moderate
X۵ ٧ ۶ .٧ ٩
۶ ٣ .۶ -٨ ٧ .٠ ٧ ۶ .۶ ١
٧ ٠ .۵ -٩ ١ .٢ ۴ .٧ ۶
٠ .٣ ٢ ٧ ۶ .٩ ٨ ۶ .۴
R٢ ٠ ۶ ٠ .١ ٣
۴ ٨ .١ -۶ ۵ .٠ ٨ ٢ .٣ ۵
٧ ١ .۴ -٩ ٠ .٨ ٢ .٣ ۶
٠ .٧ ٠ ۶ ١ .۵ ۶ ٨ .٠ Severe
X۵ ٧ ۴ .٧ ٩
۶ ٣ .۶ -٨ ٧ .٠ ٨ ١ .۶ ١
٧ ٢ .۶ -٨ ٨ .٩ ۴ .٧ ۴
٠ .٢ ٩ ٧ ٢ .۴ ٨ ٨ .٣
LR: Positive likelihood ratio, -LR: Negative likelihood ratio, +PV: Positive predictive value, -PV: Negative predictive value.
Discussion:
This study compared the accuracy of IOS with spirometry measurements for detection of COPD severity. In our study among COPD patients, sensitivity for X۵ (the best value in IOS measurements in severe COPD group) was٧ ۴ % and in mild group, sensitivity of R٢ ٠ (the best value in IOS measurements in the mild group) was ٨ ١ %.
In ٢ ٠ ٠ ٧, Al-Mutairi et al, showed ١ ٩ .۶ % sensitivity for conventional pulmonary function tests. They revealed٣ ٨ .٩ ۵ % sensitivity for IOS in COPD and۴ ٧ .۴ % sensitivity for conventional pulmonary function tests.
The sensitivity of IOS was۴ ۵ .٨ % for detecting healthy people, and was superior to that of PFT (٢ ٨ .٨ %). There was٨ ٠ .۵ % specificity for IOS and٨ ۶ .٢ % for cPFT in detecting healthy people (A١-Mutairiet al.,٢ ٠ ٠ ٧). In
۵ ۱۱ ۱۰۰۶-۱۰۰۹ ۲۰۱۱ Aust. J. Basic & Appl. Sci., ( ): ,
١ ٠ ٠ ٨
contrast with Al-Mutairi study, our findings showed greater sensitivity and specificity for IOS.
In٢ ٠ ٠ ٩, Winkleret al. detected٨ ٧ -٩ ۴ % of COPD patients by using different IOS measurements (Winkler et al.,٢ ٠ ٠ ٩).
IOS resistance values can be useful for mild COPD diagnosis and small-airway changes after bronchodilator and bronchoprovocation challenges (Winkleret al., ٢ ٠ ٠ ٩; Kanda et al., ٢ ٠ ١ ٠) but reactance values would do better for detecting the progression of COPD (Kubota et al., ٢ ٠ ٠ ٩; Paredi et al., ٢ ٠ ١ ٠).
Increased Rrs at a higher frequency (٢ ٠ Hz) reflects an increased resistance in central airways (Parket al., ٢ ٠ ١ ١). This study found higher sensitivity of resistance compared to reactance measurements in mild group, but sensitivity of reactance measurements was greater in moderate and severe COPD patients. The present study confirms the considerable sensitivity of IOS for detection of mild COPD.
Recent studies suggest that X۵ analysis can differentiate mild COPD patients better than whole-breath IOS;
Inspiratory evaluation of IOS is more accurate than expiratory evaluation ( et al.,٢ ٠ ٠ ۵; Parket al.,٢ ٠ ١ ١; Kandaet al.,٢ ٠ ١ ٠ ).
Conclusion:
Over all, IOS can be used as an alternative of spirometry to assess COPD severity in patients with minimal cooperation. In new patients suspected to COPD, IOS is a useful measurement for obtaining further details regarding lung function and mild COPD.
AKNOWLEGEMENT
We wish to thank Mrs. Sepideh Amiri for her assistance in statistical analysis of data.
Abbreviations:
COPD: Chronic Obstructive Pulmonary Disease FEV١: Forced Expiratory Volume in one second FVC: Forced Vital Capacity
IOS: Impulse Oscillometry system R٢ ٠: Resistance at٢ ٠ Hz
X۵: Reactance at۵ Hz PEF: Peak Expiratory Flow RV: Residual Volume TLC: Total Lung Capacity
REFERENCES
A١-Mutairi, S.S., P.N. Sharma, A. A١-A١awi, J.S. A١-Deen, ٢ ٠ ٠ ٧. Impulse oscillometry: an alternative modality to the conventional pulmonary function test to categorise obstructive pulmonary disorders. Clin Exp Med.,٧(٢):۵ ۶-۶ ۴.
Cooper, C.B., ٢ ٠ ٠ ۵. Assessment of pulmonary function in COPD. Semin Respir Crit Care Med.,٢ ۶(٢):
٢ ۴ ۶ -٢ ۵ ٢.
Halbert, R.J., J.L. Natoli, A. Gano, E. Badamgarav, A.S. Buist, D.M. Mannino, ٢ ٠ ٠ ۶. Global burden of COPD: systematic review and meta-analysis. Eur Respir J.,٢ ٨(٣):۵ ٢ ٣ -۵ ٣ ٢.
Kanda, S., K. Fujimoto, Y. Komatsu, M. Yasuo, M. Hanaoka, K. Kubo, ٢ ٠ ١ ٠. Evaluation of respiratory impedance in asthma and COPD by an impulse oscillation system. Intern Med.,۴ ٩(l):٢ ٣ -٣ ٠.
Kolsu, U., Z. Borrill, K. Roy, C. Starkey, J. Vestbo, C. Houghton, ٢ ٠ ٠ ٩. Impulse oscillometry in COPD:
identification of measurements related to airway obstruction, airway conductance and lung vo١mnes. Respir Med.,١ ٠ ٣(١):١ ٣ ۶ -١ ۴ ٣.
Kubota, M., G. Shirai, T. Nakamori, K. Kokubo, N. Masuda, H. Kobayashi, ٢ ٠ ٠ ٩. Low frequency oscillometry parameters in COPD patients are less variable during inspiration than during expiration. Respir Physiol Neurobiol.,١ ۶ ۶(٢):٧ ٣ -٧ ٩.
Laprad, A.S., K.R. Lutchen,٢ ٠ ٠ ٨. Respiratory impedance measurements for assessment of lung mechanics:
focus on asthma. Respir Physiol Neurobio.,١ ۶ ٣(١ -٣):۶ ۴ -٧ ٣.
Paredi, P., M. Goldman, A. Alamen, P. Ausin, O.S. Usmani, N.B. Pride,٢ ٠ ١ ٠. Comparison of inspiratory and expiratory resistance and reactance in patients with asthma and chronic obstructive pulmonary disease.
Thorax,۶ ۵(٣):٢ ۶ ٣ -٢ ۶ ٧.
Park, J.H., J.W. Yoon, Y.H. Shin, H.M. Jee, Y.S. Wee, S.J. Chang, J.H. Sim, H.Y. Yum, M.Y. Han,٢ ٠ ١ ١. Reference values for respiratory system impedance using impulse oscillometry in healthy preschool children.
Korean J Pediatr,۵ ۴(٢):۶ ۴ -۶ ٨.
۵ ۱۱ ۱۰۰۶-۱۰۰۹ ۲۰۱۱ Aust. J. Basic & Appl. Sci., ( ): ,
١ ٠ ٠ ٩
Rabe, K.F., S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, P. Calverley, Y. Fukuchi, C. Jenkins, R.
Rodriguez-Roisin, C. van Weel, J. Zielinski, ٢ ٠ ٠ ٧. Global Initiative for Chronic Obstructive Lung Disease.
Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary,١ ٧ ۶(۶):۵ ٣ ٢ -۵ ۵ ۵.
Winkler, J., A. Hagert-Winkler, H. Wirtz, G. Hoheisel,٢ ٠ ٠ ٩. Modern impulse oscillometry in the spectrum of pulmonary function testing methods. Pneumologie,۶ ٣(٨):۴ ۶ ١ -۴ ۶ ٩.